SICURANZA ANNA | Elenco docenti

Caggiano, V., Sbalchiero, J., Frassi, M., Martin-Nares, E., Hinojosa-Azaola, A., Sikora, M., et al. (2026). Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries. FRONTIERS IN MEDICINE, 12 [10.3389/fmed.2025.1659758]. - dettaglio
Gavioli, F., Caggiano, V., Sbalchiero, J., Frassi, M., Crisafulli, F., Cavazzana, I., et al. (2026). VEXAS syndrome and cancer: Insights about a possible “Tip of the Iceberg”. Ambidirectional data from the international AIDA network registries. SEMINARS IN ARTHRITIS AND RHEUMATISM, 77 [10.1016/j.semarthrit.2026.152932]. - dettaglio
Caroni, F., Sammartano, V., Pacelli, P., Sicuranza, A., Malchiodi, M., Dragomir, A., et al. (2025). Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies. PHARMACEUTICALS, 18(2) [10.3390/ph18020159]. - dettaglio
Sicuranza, A., Cavalleri, A., Bernardi, S. (2025). The biology of chronic myeloid leukemia: an overview of the new insights and biomarkers. FRONTIERS IN ONCOLOGY, 15 [10.3389/fonc.2025.1546813]. - dettaglio
Sammartano, V., Sicuranza, A., Pacelli, P., Bestoso, E., Santoni, A., Brambilla, C.Z., et al. (2025). Prognostic value of CD47 overexpression measured by flow cytometry in acute myeloid leukemia. ANNALS OF HEMATOLOGY, 104(5), 2737-2743 [10.1007/s00277-025-06401-2]. - dettaglio